A Safety Study of Pimavanserin in Adult and Elderly Subjects Experiencing Neuropsychiatric Symptoms Related to Neurodegenerative Disease
Clinical trial NCT03575052 · COMPLETED
Trial details
- NCT number
- NCT03575052
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-21
- Primary completion
- 2022-05-06
- Enrollment
- 784
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.